Cognition or genetics? Predicting Alzheimer's disease with practice effects, APOE genotype, and brain metabolism

Neurobiology of Aging
Javier Oltra-CucarellaAlzheimer's Disease Neuroimaging Initiative

Abstract

As practice effects are common in neuropsychological assessment, this study analyzed their utility to identify individuals with amnestic mild cognitive impairment (aMCI) at the greatest risk for Alzheimer's disease (AD-risk) and compared practice effects with APOE and brain metabolism biomarkers. We regressed Auditory Verbal Learning Test delayed recall (AVLT-DR) at 6 months on baseline AVLT-DR scores in 394 individuals with normal cognition from the Alzheimer's Disease Neuroimaging Initiative database and dichotomized 816 individuals with aMCI as showing practice effect or not showing practice effects (PE-) when the discrepancy between observed and predicted scores was found in less than 10%, 7%, and 5% of normal cognition. Cox regressions analyzed the AD-risk at 6 years. More than 60% of aMCI were showing practice effects. Controlling for age, sex, education, and baseline Mini-Mental State Examination and AVLT-DR scores, the AD-risk was associated with PE- [hazard ratio (HR) = 1.93], lower brain metabolism (HR = 0.95), and APOE genotype (HR = 1.92), with narrower risk estimates for PE-. The lack of practice effects during a 6-month period might be as precise as biomarkers for predicting the 6-year AD-risk.

References

Apr 6, 1999·Archives of Neurology·R C PetersenE Kokmen
Dec 5, 2006·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Kevin DuffUNKNOWN Huntington's Study Group
Jul 11, 2008·International Journal of Geriatric Psychiatry·Antoinette E ZehnderRené Spiegel
Aug 8, 2009·Neurobiology of Aging·Susan M LandauUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 6, 2010·Alzheimer's Research & Therapy·Larry G Brooks, David A Loewenstein
Apr 16, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·Lyzel S Elias-SonnenscheinPieter Jelle Visser
Jul 19, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Karl HerholzGraham Dunn
Oct 26, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Kevin DuffRobert J McCaffrey
Mar 3, 2012·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Kevin Duff
May 1, 2012·The Clinical Neuropsychologist·Matthew CalamiaDaniel Tranel
Jul 21, 2012·Dementia and Geriatric Cognitive Disorders·Kevin DuffKathryn Dennett
Mar 29, 2013·Annals of Neurology·Susan M LandauUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 13, 2014·Alzheimer Disease and Associated Disorders·Kevin DuffJohn M Hoffman
May 14, 2014·Annual Review of Neuroscience·Jin-Tai YuJohn Hardy
May 27, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Emily C EdmondsUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 30, 2015·The Cochrane Database of Systematic Reviews·Nadja SmailagicChristos Sachpekidis
Apr 25, 2015·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Kevin DuffJohn M Hoffman
May 27, 2015·Neuropsychology·Jason HassenstabJohn C Morris
Mar 1, 2015·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Terry E GoldbergLon S Schneider
Sep 21, 2016·Journal of Clinical and Experimental Neuropsychology·Kevin DuffDustin B Hammers
May 11, 2018·Journal of the American Geriatrics Society·Javier Oltra-CucarellaUNKNOWN Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯

Citations

Aug 1, 2020·Journal of Geriatric Psychiatry and Neurology·Maria Stefania De SimoneGiovanni Augusto Carlesimo
Jul 17, 2020·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Roos J JuttenLaura A Rabin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Related Papers

Dementia and Geriatric Cognitive Disorders
Samrah AhmedJohn R Hodges
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition
Maurizio GallucciEnrico Di Giorgi
Alzheimer Disease and Associated Disorders
Soojeong ShinAlzheimer’s Disease Neuroimaging Initiative
Journal of Alzheimer's Disease : JAD
Erin E SundermannAlzheimer’s Disease Neuroimaging Initiative
© 2022 Meta ULC. All rights reserved